News
The company will use the funds to expand Dreem Health, scale nationwide and advance its FDA-cleared sleep apnea technology.
The Series D funding brings the company’s total raise to $275 million and its valuation to more than $1 billion.
The company's AI agents handle scheduling, benefit checks, prior authorization claims status and billing.
The company anticipates doubling its revenue this year reaching $1 billion in sales.
The integrated platform will combine patient engagement, care access, provider data management, price transparency and payment tools.
At Healthcare 2023, panelists highlighted how new primary care and patient communication models are enabling patients to stay more connected to the healthcare system.
The company stated Capital Rx will still operate as its pharmacy benefits manager brand under Judi Health.
At Healthcare 2030, panelists highlighted successful programs at the VA and other government agencies that included integrating digital tools like remote monitoring and AI scribes.
The funds will be used to expand its customer base and invest in AI innovation.
At Healthcare 2030 in Washington, D.C., panelists highlighted debated challenges around interoperability, FHIR adoption and the need for industry-wide standards.